Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Sep 11 - Sep 16
BPC-157 Protocol (2 mL Reconstitution = 2.5 mg/mL) Route: Subcutaneous injection, preferably near the site of injury
Metabolic Pharmaceuticals Pty Ltd
Prevention and early detection are viewed as opportunities that could lead to substantial gains in PDAC-related outcomes
Research combining the two compounds has consistently shown outcomes that exceed either compound individually in musculoskeletal healing models
BPC-157 is a synthetic peptide derived from a protein found in human gastric juice, composed of 15 amino acids, and studied extensively across preclinical research models
Similarities: Both are FDA-approved Wegovy formulations Both use semaglutide as the active ingredient Both follow a gradual dose-increase schedule determined by a provider Side effects are generally similar and can be managed with provider support Differences: Wegovy pen: Taken as a once-weekly injection Wegovy pill: Taken orally once per day Your Shed provider will help determine which option may be appropriate based on your health history, preferences, and treatment goals
US$ 29.10
US$ 23.03
US$ 27.78
US$ 29.09
US$ 26.12
US$ 21.41
US$ 22.45
US$ 20.62